Diabetespatienten mit terminaler Niereninsuffizienz

Zurück zum Zitat Canada-USA (CANUSA) Peritoneal Dialysis Study Group (1996) Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 7:198–207 Canada-USA (CANUSA) Peritoneal Dialysis Study Group (1996) Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 7:198–207

Zurück zum Zitat Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, Ukpds G (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63:225–232CrossRefPubMed Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, Ukpds G (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63:225–232CrossRefPubMed

Zurück zum Zitat American Diabetes A (2010) Standards of medical care in diabetes--2010. Diabetes Care 33(Suppl 1):S11–S61CrossRef American Diabetes A (2010) Standards of medical care in diabetes--2010. Diabetes Care 33(Suppl 1):S11–S61CrossRef

Zurück zum Zitat Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J (1994) Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330:15–18CrossRefPubMed Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J (1994) Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330:15–18CrossRefPubMed

Zurück zum Zitat Braun N, Fritz P, Biegger D, Kimmel M, Reimold F, Ulmer C, Alscher MD (2011) Difference in the expression of hormone receptors and fibrotic markers in the human peritoneum – implications for therapeutic targets to prevent encapsulating peritoneal sclerosis. Perit Dial Int 31:291–300CrossRefPubMed Braun N, Fritz P, Biegger D, Kimmel M, Reimold F, Ulmer C, Alscher MD (2011) Difference in the expression of hormone receptors and fibrotic markers in the human peritoneum – implications for therapeutic targets to prevent encapsulating peritoneal sclerosis. Perit Dial Int 31:291–300CrossRefPubMed

Zurück zum Zitat Chou CY, Liang CC, Kuo HL, Chang CT, Liu JH, Lin HH, Wang IK, Yang YF, Huang CC (2014) Comparing risk of new onset diabetes mellitus in chronic kidney disease patients receiving peritoneal dialysis and hemodialysis using propensity score matching. PLOS ONE 9:e87891CrossRefPubMedPubMedCentral Chou CY, Liang CC, Kuo HL, Chang CT, Liu JH, Lin HH, Wang IK, Yang YF, Huang CC (2014) Comparing risk of new onset diabetes mellitus in chronic kidney disease patients receiving peritoneal dialysis and hemodialysis using propensity score matching. PLOS ONE 9:e87891CrossRefPubMedPubMedCentral

Zurück zum Zitat Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA (2010) A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363:609–619CrossRefPubMed Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA (2010) A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363:609–619CrossRefPubMed

Zurück zum Zitat Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS (2009) Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006. Diabetes Care 32:287–294CrossRefPubMedPubMedCentral Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS (2009) Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006. Diabetes Care 32:287–294CrossRefPubMedPubMedCentral

Zurück zum Zitat Davies SJ (2004) Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 66:2437–2445CrossRefPubMed Davies SJ (2004) Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 66:2437–2445CrossRefPubMed

Zurück zum Zitat Dong J, Yang ZK, Chen Y (2016) Older age, higher body mass index and inflammation increase the risk for new-onset diabetes and impaired glucose tolerance in patients on peritoneal dialysis. Perit Dial Int 36:277–283CrossRefPubMed Dong J, Yang ZK, Chen Y (2016) Older age, higher body mass index and inflammation increase the risk for new-onset diabetes and impaired glucose tolerance in patients on peritoneal dialysis. Perit Dial Int 36:277–283CrossRefPubMed

Zurück zum Zitat Finne P, Reunanen A, Stenman S, Groop PH, Gronhagen-Riska C (2005) Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 294:1782–1787CrossRefPubMed Finne P, Reunanen A, Stenman S, Groop PH, Gronhagen-Riska C (2005) Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 294:1782–1787CrossRefPubMed

Zurück zum Zitat Frank RN (2004) Diabetic retinopathy. N Engl J Med 350:48–58CrossRefPubMed Frank RN (2004) Diabetic retinopathy. N Engl J Med 350:48–58CrossRefPubMed

Zurück zum Zitat Han SH, Ahn SV, Yun JY, Tranaeus A, Han DS (2009) Mortality and technique failure in peritoneal dialysis patients using advanced peritoneal dialysis solutions. Am J Kidney Dis 54:711–720CrossRefPubMed Han SH, Ahn SV, Yun JY, Tranaeus A, Han DS (2009) Mortality and technique failure in peritoneal dialysis patients using advanced peritoneal dialysis solutions. Am J Kidney Dis 54:711–720CrossRefPubMed

Zurück zum Zitat Himmele R, Jensen L, Fenn D, Ho CH, Sawin DA, Diaz-Buxo JA (2012) A new neutral-pH low-GDP peritoneal dialysis fluid. Perit Dial Int 32:444–452CrossRefPubMedPubMedCentral Himmele R, Jensen L, Fenn D, Ho CH, Sawin DA, Diaz-Buxo JA (2012) A new neutral-pH low-GDP peritoneal dialysis fluid. Perit Dial Int 32:444–452CrossRefPubMedPubMedCentral

Zurück zum Zitat Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT (2002) Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62:1046–1053CrossRefPubMed Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT (2002) Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62:1046–1053CrossRefPubMed

Zurück zum Zitat Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MW, Jones B, Kulkarni H, Langham R, Ranganathan D, Schollum J, Suranyi MG, Tan SH, Voss D (2012) The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial. Nephrol Dial Transplant 27(12):4445. https://doi.org/10.1093/ndt/gfs314 CrossRefPubMedPubMedCentral Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MW, Jones B, Kulkarni H, Langham R, Ranganathan D, Schollum J, Suranyi MG, Tan SH, Voss D (2012) The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial. Nephrol Dial Transplant 27(12):4445. https://​doi.​org/​10.​1093/​ndt/​gfs314 CrossRefPubMedPubMedCentral

Zurück zum Zitat Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ (2003) Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3:178–185CrossRefPubMed Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ (2003) Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3:178–185CrossRefPubMed

Zurück zum Zitat Kramer A, Pippias M, Stel VS, Bonthuis M, Abad Diez JM, Afentakis N, Alonso de la Torre R, Ambuhl P, Bikbov B, Bouzas Caamano E, Bubic I, Buturovic-Ponikvar J, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Comas Farnes J, Garcia Bazaga Mde L, De Meester J, Ferrer Alamar M, Finne P, Garneata L, Golan E, Heaf GJ, Hemmelder M, Ioannou K, Kantaria N, Kolesnyk M, Kramar R, Lassalle M, Lezaic V, Lopot F, Macario F, Magaz A, Martin-Escobar E, Metcalfe W, Ots-Rosenberg M, Palsson R, Pinera Celestino C, Resic H, Rutkowski B, Santiuste de Pablos C, Spustova V, Stendahl M, Strakosha A, Suleymanlar G, Torres Guinea M, Varberg Reisaeter A, Vazelov E, Ziginskiene E, Massy ZA, Wanner C, Jager KJ, Noordzij M (2016) Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus. Clin Kidney J 9:457–469CrossRefPubMedPubMedCentral Kramer A, Pippias M, Stel VS, Bonthuis M, Abad Diez JM, Afentakis N, Alonso de la Torre R, Ambuhl P, Bikbov B, Bouzas Caamano E, Bubic I, Buturovic-Ponikvar J, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Comas Farnes J, Garcia Bazaga Mde L, De Meester J, Ferrer Alamar M, Finne P, Garneata L, Golan E, Heaf GJ, Hemmelder M, Ioannou K, Kantaria N, Kolesnyk M, Kramar R, Lassalle M, Lezaic V, Lopot F, Macario F, Magaz A, Martin-Escobar E, Metcalfe W, Ots-Rosenberg M, Palsson R, Pinera Celestino C, Resic H, Rutkowski B, Santiuste de Pablos C, Spustova V, Stendahl M, Strakosha A, Suleymanlar G, Torres Guinea M, Varberg Reisaeter A, Vazelov E, Ziginskiene E, Massy ZA, Wanner C, Jager KJ, Noordzij M (2016) Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus. Clin Kidney J 9:457–469CrossRefPubMedPubMedCentral

Zurück zum Zitat Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR (1985) The changing natural history of nephropathy in type I diabetes. Am J Med 78:785–794CrossRefPubMed Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR (1985) The changing natural history of nephropathy in type I diabetes. Am J Med 78:785–794CrossRefPubMed

Zurück zum Zitat Krolewski M, Eggers PW, Warram JH (1996) Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int 50:2041–2046CrossRefPubMed Krolewski M, Eggers PW, Warram JH (1996) Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int 50:2041–2046CrossRefPubMed

Zurück zum Zitat Lameire N, Van Biesen W (2010) Epidemiology of peritoneal dialysis: a story of believers and nonbelievers. Nat Rev Nephrol 6:75–82CrossRefPubMed Lameire N, Van Biesen W (2010) Epidemiology of peritoneal dialysis: a story of believers and nonbelievers. Nat Rev Nephrol 6:75–82CrossRefPubMed

Zurück zum Zitat Lee MJ, Kwon YE, Park KS, Kee YK, Yoon CY, Han IM, Han SG, Oh HJ, Park JT, Han SH, Yoo TH, Kim YL, Kim YS, Yang CW, Kim NH, Kang SW (2016) Glycemic control modifies difference in mortality risk between hemodialysis and peritoneal dialysis in incident dialysis patients with diabetes: results from a nationwide prospective cohort in Korea. Medicine (Baltimore) 95:e3118CrossRef Lee MJ, Kwon YE, Park KS, Kee YK, Yoon CY, Han IM, Han SG, Oh HJ, Park JT, Han SH, Yoo TH, Kim YL, Kim YS, Yang CW, Kim NH, Kang SW (2016) Glycemic control modifies difference in mortality risk between hemodialysis and peritoneal dialysis in incident dialysis patients with diabetes: results from a nationwide prospective cohort in Korea. Medicine (Baltimore) 95:e3118CrossRef

Zurück zum Zitat Li PK, Culleton BF, Ariza A, Do JY, Johnson DW, Sanabria M, Shockley TR, Story K, Vatazin A, Verrelli M, Yu AW, Bargman JM, Groups ES (2013) Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J Am Soc Nephrol 24:1889–1990CrossRefPubMedPubMedCentral Li PK, Culleton BF, Ariza A, Do JY, Johnson DW, Sanabria M, Shockley TR, Story K, Vatazin A, Verrelli M, Yu AW, Bargman JM, Groups ES (2013) Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients. J Am Soc Nephrol 24:1889–1990CrossRefPubMedPubMedCentral

Zurück zum Zitat Lin X, Lin A, Ni Z, Yao Q, Zhang W, Yan Y, Fang W, Gu A, Axelsson J, Qian J (2010) Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients. Nephrol Dial Transplant 25:2322–2327CrossRefPubMed Lin X, Lin A, Ni Z, Yao Q, Zhang W, Yan Y, Fang W, Gu A, Axelsson J, Qian J (2010) Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients. Nephrol Dial Transplant 25:2322–2327CrossRefPubMed

Zurück zum Zitat Lukowsky LR, Mehrotra R, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K (2013) Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis. Clin J Am Soc Nephrol 8:619–628CrossRefPubMedPubMedCentral Lukowsky LR, Mehrotra R, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K (2013) Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis. Clin J Am Soc Nephrol 8:619–628CrossRefPubMedPubMedCentral

Zurück zum Zitat Machowska A, Alscher MD, Vanga SR, Koch M, Aarup M, Qureshi AR, Lindholm B, Rutherford P (2017) Dialysis access, infections, and hospitalisations in unplanned dialysis start patients: results from the OPTiONS study. Int J Artif Organs 40:48–59CrossRefPubMed Machowska A, Alscher MD, Vanga SR, Koch M, Aarup M, Qureshi AR, Lindholm B, Rutherford P (2017) Dialysis access, infections, and hospitalisations in unplanned dialysis start patients: results from the OPTiONS study. Int J Artif Organs 40:48–59CrossRefPubMed

Zurück zum Zitat Machowska A, Alscher MD, Vanga SR, Koch M, Aarup M, Qureshi AR, Lindholm B, Rutherford P (2017) Offering Patients Therapy Options in Unplanned Start (OPTiONS): implementation of an educational program is feasible and effective. BMC Nephrol 18:18CrossRefPubMedPubMedCentral Machowska A, Alscher MD, Vanga SR, Koch M, Aarup M, Qureshi AR, Lindholm B, Rutherford P (2017) Offering Patients Therapy Options in Unplanned Start (OPTiONS): implementation of an educational program is feasible and effective. BMC Nephrol 18:18CrossRefPubMedPubMedCentral

Zurück zum Zitat Matsushima M, Tajima N, LaPorte RE, Orchard TJ, Tull ES, Gower IF, Kitagawa T (1995) Markedly increased renal disease mortality and incidence of renal replacement therapy among IDDM patients in Japan in contrast to Allegheny County, Pennsylvania, USA. Diabetes Epidemiology Research International (DERI) U.S.-Japan Mortality Study Group. Diabetologia 38:236–243CrossRefPubMed Matsushima M, Tajima N, LaPorte RE, Orchard TJ, Tull ES, Gower IF, Kitagawa T (1995) Markedly increased renal disease mortality and incidence of renal replacement therapy among IDDM patients in Japan in contrast to Allegheny County, Pennsylvania, USA. Diabetes Epidemiology Research International (DERI) U.S.-Japan Mortality Study Group. Diabetologia 38:236–243CrossRefPubMed

Zurück zum Zitat McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR (2009) Relationship between dialysis modality and mortality. J Am Soc Nephrol 20:155–163CrossRefPubMedPubMedCentral McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR (2009) Relationship between dialysis modality and mortality. J Am Soc Nephrol 20:155–163CrossRefPubMedPubMedCentral

Zurück zum Zitat Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E (2011) Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 171:110–118CrossRefPubMed Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E (2011) Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 171:110–118CrossRefPubMed

Zurück zum Zitat Mehrotra R, Chiu YW, Kalantar-Zadeh K, Vonesh E (2009) The outcomes of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int 76:97–107CrossRefPubMed Mehrotra R, Chiu YW, Kalantar-Zadeh K, Vonesh E (2009) The outcomes of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int 76:97–107CrossRefPubMed

Zurück zum Zitat Mizumasa T, Hirakata H, Kuroki Y, Katafuchi R, Yotsueda H, Mitsuiki K, Nakashima Y, Tsuruya K (2013) Diabetes influences peritoneal morphology in uremic patients at the initiation of peritoneal dialysis. Perit Dial Int 33:175–181CrossRefPubMedPubMedCentral Mizumasa T, Hirakata H, Kuroki Y, Katafuchi R, Yotsueda H, Mitsuiki K, Nakashima Y, Tsuruya K (2013) Diabetes influences peritoneal morphology in uremic patients at the initiation of peritoneal dialysis. Perit Dial Int 33:175–181CrossRefPubMedPubMedCentral

Zurück zum Zitat Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE (2000) Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 11:556–564PubMed Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE (2000) Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 11:556–564PubMed

Zurück zum Zitat Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79CrossRefPubMed Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79CrossRefPubMed

Zurück zum Zitat Nacak H, Bolignano D, Van Diepen M, Dekker F, Van Biesen W (2016) Timing of start of dialysis in diabetes mellitus patients: a systematic literature review. Nephrol Dial Transplant 31:306–316PubMed Nacak H, Bolignano D, Van Diepen M, Dekker F, Van Biesen W (2016) Timing of start of dialysis in diabetes mellitus patients: a systematic literature review. Nephrol Dial Transplant 31:306–316PubMed

Zurück zum Zitat Nelson CB, Port FK, Wolfe RA, Guire KE (1992) Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s. J Am Soc Nephrol 3:1147–1155PubMed Nelson CB, Port FK, Wolfe RA, Guire KE (1992) Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s. J Am Soc Nephrol 3:1147–1155PubMed

Zurück zum Zitat Rippe B, Davies S (2011) Permeability of peritoneal and glomerular capillaries: what are the differences according to pore theory? Perit Dial Int 31:249–258CrossRefPubMed Rippe B, Davies S (2011) Permeability of peritoneal and glomerular capillaries: what are the differences according to pore theory? Perit Dial Int 31:249–258CrossRefPubMed

Zurück zum Zitat Tien KJ, Lin ZZ, Chio CC, Wang JJ, Chu CC, Sun YM, Kan WC, Chien CC (2013) Epidemiology and mortality of new-onset diabetes after dialysis: Taiwan national cohort study. Diabetes Care 36:3027–3032CrossRefPubMedPubMedCentral Tien KJ, Lin ZZ, Chio CC, Wang JJ, Chu CC, Sun YM, Kan WC, Chien CC (2013) Epidemiology and mortality of new-onset diabetes after dialysis: Taiwan national cohort study. Diabetes Care 36:3027–3032CrossRefPubMedPubMedCentral

Zurück zum Zitat U.S. Renal Data System UADR (2012) Atlas of chronic kidney disease and end- stage renal disease in the United States, 2012. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda U.S. Renal Data System UADR (2012) Atlas of chronic kidney disease and end- stage renal disease in the United States, 2012. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda

Zurück zum Zitat van de Luijtgaarden MW, Jager KJ, Segelmark M, Pascual J, Collart F, Hemke AC, Remon C, Metcalfe W, Miguel A, Kramar R, Aasarod K, Hanna AA, Krediet RT, Schon S, Ravani P, Caskey FJ, Couchoud C, Palsson R, Wanner C, Finne P, Noordzij M (2016) Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period. Nephrol Dial Transplant 31:120–128CrossRefPubMed van de Luijtgaarden MW, Jager KJ, Segelmark M, Pascual J, Collart F, Hemke AC, Remon C, Metcalfe W, Miguel A, Kramar R, Aasarod K, Hanna AA, Krediet RT, Schon S, Ravani P, Caskey FJ, Couchoud C, Palsson R, Wanner C, Finne P, Noordzij M (2016) Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period. Nephrol Dial Transplant 31:120–128CrossRefPubMed

Zurück zum Zitat Vonesh EF, Snyder JJ, Foley RN, Collins AJ (2004) The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 66:2389–2401CrossRefPubMed Vonesh EF, Snyder JJ, Foley RN, Collins AJ (2004) The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 66:2389–2401CrossRefPubMed

Zurück zum Zitat Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ (2010) Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 21:499–506CrossRefPubMedPubMedCentral Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ (2010) Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 21:499–506CrossRefPubMedPubMedCentral

Zurück zum Zitat Williams JD, Craig KJ, von Ruhland C, Topley N, Williams GT (2003) The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 88:S43–S49CrossRef Williams JD, Craig KJ, von Ruhland C, Topley N, Williams GT (2003) The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 88:S43–S49CrossRef

Zurück zum Zitat Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J, National CD, Metabolic Disorders Study G (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362:1090–1101CrossRefPubMed Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J, National CD, Metabolic Disorders Study G (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362:1090–1101CrossRefPubMed

Zurück zum Zitat Yang X, Yi C, Liu X, Guo Q, Yang R, Cao P, Lin J, Mao H, Yu X (2013) Clinical outcome and risk factors for mortality in Chinese patients with diabetes on peritoneal dialysis: a 5-year clinical cohort study. Diabetes Res Clin Pract 100:354–361CrossRefPubMed Yang X, Yi C, Liu X, Guo Q, Yang R, Cao P, Lin J, Mao H, Yu X (2013) Clinical outcome and risk factors for mortality in Chinese patients with diabetes on peritoneal dialysis: a 5-year clinical cohort study. Diabetes Res Clin Pract 100:354–361CrossRefPubMed

Zurück zum Zitat Yeates K, Zhu N, Vonesh E, Trpeski L, Blake P, Fenton S (2012) Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant 27:3568–3575CrossRefPubMed Yeates K, Zhu N, Vonesh E, Trpeski L, Blake P, Fenton S (2012) Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant 27:3568–3575CrossRefPubMed